South Africa has moved to halt its rollout of the Oxford/AstraZeneca vaccine after preliminary and limited evidence showed it failed to protect against mild and moderate forms of disease caused by a coronavirus variant first detected in the country.
南非已决定暂停牛津/阿斯利康(Oxford/AstraZeneca)新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）疫苗接种计划。此前，有初步和有限的证据显示，这款疫苗未能预防最早在该国发现的新冠病毒变体引发的轻中症。
您已阅读6%（363字），剩余94%（5353字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。